References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:https://doi.org/10.3322/caac.21332
- Ingrosso G, Detti B, Scartoni D, Lancia A, Giacomelli I, Baki M, Carta G, Livi L, Santoni R. Current therapeutic options in metastatic castration-resistant prostate cancer. Semin Oncol. 2018;45(5–6):303–15. doi:https://doi.org/10.1053/j.seminoncol.2018.10.001
- Heidegger I, Massoner P, Eder IE, Pircher A, Pichler R, Aigner F, Bektic J, Horninger W, Klocker H. Novel therapeutic approaches for the treatment of castration-resistant prostate cancer. J Steroid Biochem Mol Biol. 2013;138:248–56. doi:https://doi.org/10.1016/j.jsbmb.2013.06.002
- McNeel DG, Bander NH, Beer TM, et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma. J Immunother Cancer. 2016;4:92. https://doi.org/10.1186/s40425-016-0198-x
- Tilki D, Evans CP. The changing landscape of advanced and castration resistant prostate cancer: latest science and revised definitions. Can J Urol. 2014;21(2 Supp 1):7–13. https://www.canjurol.com/html/free-articles/V21I2S1-02_DrTilki.pdf
- Wu JN, Fish KM, Evans CP, deVere White RW, Dall’Era MA. No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period. Cancer. 2014;120(6):818–23. doi:https://doi.org/10.1002/cncr.28485
- Hussain SS, Kumar AP, Ghosh R. Food-based natural products for cancer management: is the whole greater than the sum of the parts?Semin Cancer Biol. 2016;40–41:233–46. doi:https://doi.org/10.1016/j.semcancer.2016.06.002
- Klempner SJ, Bubley G. Complementary and alternative medicines in prostate cancer: from bench to bedside. Oncologist. 2012;17(6):830–7. doi:https://doi.org/10.1634/theoncologist.2012-0094
- Philippou Y, Hadjipavlou M, Khan S, Rane A. Complementary and alternative medicine (CAM) in prostate and bladder cancer. BJU Int. 2013;112(8):1073–9. doi:https://doi.org/10.1111/bju.12062
- Boros LG, Nichelatti M, Shoenfeld Y. Fermented wheat germ extract (Avemar) in the treatment of cancer and autoimmune diseases. Ann N Y Acad Sci. 2005;1051:529–42. doi:https://doi.org/10.1196/annals.1361.097
- Telekes A, Hegedűs M, Chae C-H, Vékey K. Avemar (wheat germ extract) in cancer prevention and treatment. Nutr Cancer. 2009;61(6):891–9. doi:https://doi.org/10.1080/01635580903285114
- Heimbach JT, Sebestyén G, Semjen G, Kennepohl E. Safety studies regarding a standardized extract of fermented wheat germ. Int J Toxicol. 2007;26(3):253–9. doi:https://doi.org/10.1080/10915810701369709
- Illmer C, Madlener S, Horvath Z, Saiko P, Losert A, Herbacek I, Grusch M, Krupitza G, Fritzer-Szekeres M, Szekeres T. Immunologic and biochemical effects of the fermented wheat germ extract Avemar. Exp Biol Med (Maywood). 2005;230(2):144–9. doi:https://doi.org/10.1177/153537020523000209
- Yang M-D, Chang W-S, Tsai C-W, Wang M-F, Chan Y-C, Chan K-C, Lu M-C, Kao A-W, Hsu C-M, Bau D-T. Inhibitory effects of AVEMAR on proliferation and metastasis of oral cancer cells. Nutr Cancer. 2016;68(3):473–80. doi:https://doi.org/10.1080/01635581.2016.1153668
- Zhurakivska K, Troiano G, Caponio VCA, Dioguardi M, Arena C, Muzio LL. The effects of adjuvant fermented wheat germ extract on cancer cell lines: A systematic review. Nutrients. 2018;10(10):1546. doi:https://doi.org/10.3390/nu10101546
- Mueller T, Jordan K, Voigt W . Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines. J Exp Clin Cancer Res. 2011;30:42. doi:https://doi.org/10.1186/1756-9966-30-42
- Jakab F, Shoenfeld Y, Balogh Á, Nichelatti M, Hoffmann A, Kahán Z, Lapis K, Mayer Á, Sápy P, Szentpétery F, et al. A medical nutriment has supportive value in the treatment of colorectal cancer. Br J Cancer. 2003;89(3):465–9. doi:https://doi.org/10.1038/sj.bjc.6601153
- Barabas J, Nemeth Z. Recommendation of the Hungarian Society for Face, Mandible and Oral Surgery in the indication of supportive therapy with Avemar. Orv Hetil. 2006;147:1709–11. (In Hungarian)
- Demidov LV, Manziuk LV, Kharkevitch GY, Pirogova NA, Artamonova EV. Adjuvant fermented wheat germ extract (Avemar) nutraceutical improves survival of high-risk skin melanoma patients: a randomized, pilot, phase II clinical study with a 7-year follow-up. Cancer Biother Radiopharm. 2008;23(4):477–82. doi:https://doi.org/10.1089/cbr.2008.0486
- Sukkar SG, Cella F, Rovera GM, Nichelatti M, Ragni G, Chiavenna G, Giannoni A, Ronzani G, Ferrari C. A multicentric prospective open trial on the quality of life and oxidative stress in patients affected by advanced head and neck cancer treated with a new benzoquinone-rich product derived from fermented wheat germ (Avemar). Mediterranean J Nutr Metab. 2008;1(1):37–42. doi:https://doi.org/10.3233/s12349-008-0008-4
- Garami M, Schuler D, Babosa M, Borgulya G, Hauser P, Müller J, Paksy A, Szabó E, Hidvégi M, Fekete G. Fermented wheat germ extract reduces chemotherapy-induced febrile neutropenia in pediatric cancer patients. J Pediatr Hematol Oncol. 2004;26(10):631–5. doi:https://doi.org/10.1097/01.mph.0000141897.04996.21
- Patel S. Fermented wheat germ extract: a dietary supplement with anticancer efficacy. Nutr Ther Metab. 2014;32(2):61–7. doi:https://doi.org/10.5301/NTM.2014.12408
- Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21(3):297–308. doi:https://doi.org/10.1016/j.ccr.2012.02.014
- Marin D, Sabater B. The cancer Warburg effect may be a testable example of the minimum entropy production rate principle. Phys Biol. 2017;14(2):024001. doi:https://doi.org/10.1088/1478-3975/aa64a7
- Jiang P, Du W, Wu M. Regulation of the pentose phosphate pathway in cancer. Protein Cell. 2014;5(8):592–602. doi:https://doi.org/10.1007/s13238-014-0082-8
- Comin-Anduix B, Boros LG, Marin S, Boren J, Callol-Massot C, Centelles JJ, Torres JL, Agell N, Bassilian S, Cascante M. Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumor cells. J Biol Chem. 2002;277(48):46408–14. doi:https://doi.org/10.1074/jbc.M206150200
- Otto C, Hahlbrock T, Eich K, Karaaslan F, Jürgens C, Germer C-T, Wiegering A, Kämmerer U. Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract. BMC Complement Altern Med. 2016;16:160. doi:https://doi.org/10.1186/s12906-016-1138-5
- Eidelman E, Twum-Ampofo J, Ansari J, Siddiqui MM. The metabolic phenotype of prostate cancer. Front Oncol. 2017;7:131. doi:https://doi.org/10.3389/fonc.2017.00131
- Wang L, Wang J, Xiong H, Wu F, Lan T, Zhang Y, Guo X, Wang H, Saleem M, Jiang C, et al. Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer. EBioMedicine. 2016;7:50–61. doi:https://doi.org/10.1016/j.ebiom.2016.03.022
- Tsouko E, Khan AS, White MA, Han JJ, Shi Y, Merchant FA, Sharpe MA, Xin L, Frigo DE . Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth . Oncogenesis. 2014;3:e103. doi:https://doi.org/10.1038/oncsis.2014.18
- Shibuya N, Inoue K, Tanaka G, Akimoto K, Kubota K. Augmented pentose phosphate pathway plays critical roles in colorectal carcinomas. Oncology. 2015;88(5):309–19. doi:https://doi.org/10.1159/000369905
- Bencze G, Bencze S, Rivera KD, Watson JD, Hidvegi M, Orfi L, Tonks NK, Pappin DJ. Mito-oncology agent: fermented extract suppresses the Warburg effect, restores oxidative mitochondrial activity, and inhibits in vivo tumor growth. Sci Rep. 2020;10(1):14174. doi:https://doi.org/10.1038/s41598-020-71118-3
- Dose-dependent effect of the fermented wheat germ extract (Avemar) on the growth of human PC-3 prostate tumour. Report. Budapest: National Institute of Oncology; 2005. (In Hungarian)
- Guess B, Jennrich R, Johnson H, Redheffer R, Scholz M. Using splines to detect changes in PSA doubling times. Prostate. 2003;54(2):88–94. doi:https://doi.org/10.1002/pros.10176
- Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc. 2001;76(6):576–81. doi:https://doi.org/10.1016/S0025-6196(11)62406-3
- Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, et al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol. 2008;26(7):1148–59. doi:https://doi.org/10.1200/JCO.2007.12.4487
- Mueller T, Voigt W. Fermented wheat germ extract-nutritional supplement or anticancer drug?Nutr J. 2011;10:89. doi:https://doi.org/10.1186/1475-2891-10-89